GARDNER JASON 4
4 · Magenta Therapeutics, Inc. · Filed Dec 20, 2019
Insider Transaction Report
Form 4
GARDNER JASON
DirectorSee Remarks
Transactions
- Sale
Common Stock
2019-12-20$15.16/sh−76,711$1,162,617→ 268,109 total
Holdings
- 359,092(indirect: By Trust)
Common Stock
- 292,990(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]This trade is pursuant to an active 10b5-1 plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $15.10 to $15.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.